-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
-
Summary
-
Collegium Pharmaceutical, Inc quarterly/annual Amortization of Intangible Assets history and growth rate from Q2 2016 to Q3 2024.
- Collegium Pharmaceutical, Inc Amortization of Intangible Assets for the quarter ending September 30, 2024 was $40.8M, a 12.3% increase year-over-year.
- Collegium Pharmaceutical, Inc annual Amortization of Intangible Assets for 2021 was $67.2M, a 10.7% increase from 2020.
- Collegium Pharmaceutical, Inc annual Amortization of Intangible Assets for 2020 was $60.7M, a 311% increase from 2019.
- Collegium Pharmaceutical, Inc annual Amortization of Intangible Assets for 2019 was $14.8M, a 86.6% decline from 2018.
Amortization of Intangible Assets, Trailing 12 Months (USD)
Amortization of Intangible Assets, Quarterly (USD)
Amortization of Intangible Assets, YoY Quarterly Growth (%)